Dihydroergokryptine Vs Flunarizine in the Basic Treatment of Migraine without Aura

Horowski R “Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.” In: Critchley M. (eds) Adv. in neur., vol. 33, Raven Press, New York (1982), pag. 325–334.

Poli M. , Cocchi D. , Mailland F , Masu A.M. , Landi G. , Craveri A. , Muller E.E. “Prolactine lowering effect of dihydroergokryptine in rat and in man” J.End. Invest., (1986) 9: 31–36.

Int. Head Soc. Committee on Clin Trials in migraine “Guidelines for controlled trials of drugs in migraine” (1991).

Matthews J.N.S. B.M.J. (1990) 300, 230–235.